Genentech

Genentech, OSI to pay $67 mn to settle false claims on cancer drug Tarceva

08 Jun 2016

23andMe Inc, Genentech to analyse genomes of 3,000 Parkinson’s patients

09 Jan 2015

Genentech to pay up to $1.7 bn for oncology firm Seragon

03 Jul 2014

GSK sues Roche over Genentech's cancer drug patent infringement

23 Sep 2010

Roche confirms plans to acquire remaining 44 per cent in Genentech

21 Oct 2008

Genentech rejects Roche’s $43.7-billion takeover offer as too low

13 Aug 2008

Biotechnology giant Genentech Inc today rejected a $43.7-billion takeover bid from its majority shareholder, Roche Holding AG, as too low, while saying it would be open to a higher proposal.